Drug Target Review – Issue #1 2018

Posted: 14 March 2018 | | No comments yet

In this issue: how customised cell engineering advances immunotherapy, how insights into auto-immunity are providing new opportunities for immune-oncology, and advances in lab automation and robotics are accelerating the pace of antimicrobial therapy.

Drug target review issue 1 2018 magazine
  • FOREWORD: The role of charity support in drug discovery research
    Jan Kulagowski, Drug Discovery Manager, Parkinson’s UK
  • IMMUNO-ONCOLOGY: Lymphocytes: how customised cell engineering advances immunotherapy
    Tamara J Laskowski, MD Anderson Cancer Center
  • IN-DEPTH FOCUS: Assays
  • ONCOLOGY: Insights into auto- immunity provide new opportunities for immune-oncology
    Stuart Farrow and Christian Dillon, Cancer Research UK Therapeutic Discovery Laboratories
  • IN-DEPTH FOCUS: Lab automation
  • LIPIDOMICS: How the study of lipidomics is benefiting from recent advances in mass spectrometry
    Cristina Legido-Quigley, Diabetes Center Copenhagen, and King’s College London
  • IN-DEPTH FOCUS: Informatics
  • HIT TO LEAD: Rapidly synthesised fluorinated heterocyclic drug scaffold: accelerating the hit-to-lead process
    Avinder S Bhambra, De Montfort University, Sheraz Gul, Fraunhofer-IME, and George W Weaver, Loughborough University

Issue #1 2018 of Drug Target Review is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here